Showing results (141-150 of 648) with videos related to
Sort By:
Pageof 65
Current Opinion in Oncology|September 7, 2000
Hodgkin disease: prognostic factors and treatment strategiesA Josting, J Wolf, V DiehlSeminars in Hematology|August 26, 1999
Treatment of advanced Hodgkin's lymphoma: standard and experimental approachesA Engert, J Wolf, V DiehlAnnals of Oncology : Official Journal of the European Society for Medical Oncology|February 2, 1999
Model based development of the BEACOPP regimen for advanced stage Hodgkin's disease. German Hodgkin's Lymphoma Study GroupM Loeffler, D Hasenclever, V DiehlEuropean Journal of Immunology|December 1, 1982
The immune response against anti-idiotope antibodies. I. Induction of idiotope-bearing antibodies and analysis of the idiotope repertoireT Takemori, H Tesch, M Reth, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 1, 1996
Rationale for dose escalation of first line conventional chemotherapy in advanced Hodgkin's disease. German Hodgkin's Lymphoma Study GroupD Hasenclever, M Loeffler, V DiehlVirchows Archiv. A, Pathological Anatomy and Histology|January 1, 1980
Proliferation kinetics of malignant non-Hodgkin's lymphomas related to histopathology of lymph node biopsiesW Lang, S Kienzle, V DiehlCurrent Opinion in Oncology|November 4, 1998
Issues in the treatment of Hodgkin's diseaseJ Wolf, A Engert, V DiehlOnkologie|April 1, 1986
[Clinical relevance of immune phenotyping of malignant lymphomas]V Diehl, M Schaadt, M PfreundschuhHematological Oncology|September 2, 1998
Hodgkin's disease biology: recent advancesA Jox, J Wolf, V DiehlThe Journal of Infection|July 1, 1997
Paradoxical expansion of intracranial tuberculomas during chemotherapyM Reiser, G Fätkenheuer, V DiehlPageof 65